Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors-Reference-Cited by-同舟云学术

Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors

Published:2016-05 Issue:1-2 Volume:505 Page:89-95
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Akhtari Javad,Rezayat Seyed Mahdi,Teymouri Manouchehr,Alavizadeh Seyedeh Hoda,Gheybi Fatemeh,Badiee Ali,Jaafari Mahmoud Reza

Funder

Tehran University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Improved therapeutic activity of HER2 affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models;Alavizadeh;Exp. Opin. Drug Delivery,2016

2. HER-2-targeted nanoparticle–affibody bioconjugates for cancer therapy;Alexis;ChemMedChem,2008

3. Ligand-targeted therapeutics in anticancer therapy;Allen;Nat. Rev. Cancer,2002

4. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas;Amin;Int. J. Pharm. (Kidlington),2013

5. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin;Arabi;J. Control. Release,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy;Materials Today Advances;2023-06

2. Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors;Molecular Pharmaceutics;2023-05-03

3. Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer;Molecules;2023-03-31

4. HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment;Cancers;2022-05-13

5. Artificial Scaffold PolypeptidesAs an Efficient Tool for the Targeted Delivery of Nanostructures In Vitro and In Vivo;Acta Naturae;2022-05-10